| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Intellia Therapeutics, Inc. (NTLA) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 38 sells. NTLA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $14.47M | - | |
| Dir | 207.5K | $2.96M | - | |
| Dir | 134.7K | $1.92M | - | |
| VP | 121.2K | $1.73M | - | |
| VP | 101.5K | $1.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2021 | Formela Jean Francois70 | Director | Sell | 501,945 | $60.29 | $30,262,715.80 | -31.1% | |
| Feb 9, 2021 | Rivera Jose E | EVP, General Counsel | Sale+OE | 11,489 | $75.00 | $861,675.00 | -8.9% | |
| Feb 9, 2021 | Leonard John M83 | President And CEO | Sale+OE | 50,985 | $71.70 | $3,655,410.40 | -1.9% | |
| Feb 3, 2021 | Leonard John M83 | President And CEO | Sale+OE | 177,745 | $67.26 | $11,955,394.68 | -2.2% | |
| Feb 1, 2021 | Rivera Jose E | EVP, General Counsel | Sale+OE | 54,659 | $63.99 | $3,497,902.48 | -5.5% | |
| Jan 5, 2021 | Leonard John M83 | President And CEO | Sale+OE | 6,239 | $55.86 | $348,510.54 | -1.3% | |
| Jan 5, 2021 | Schiermeier Andrew | EVP, Chief Operating Officer | Sale+OE | 1,377 | $55.86 | $76,919.22 | -7.6% | |
| Jan 5, 2021 | Rivera Jose E | EVP, General Counsel | Sale+OE | 2,078 | $55.86 | $116,077.08 | -3.8% | |
| Dec 17, 2020 | Karsen Perry A | Director | Sale+OE | 88,764 | $53.55 | $4,753,679.94 | -46.3% | |
| Dec 1, 2020 | Rivera Jose E | EVP, General Counsel | Sale+OE | 3,364 | $38.21 | $128,525.05 | -2.2% |